Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study

NCT00586378 is registered in ClinicalTrials.gov with ELA Medical, Inc. as lead sponsor.

NCT NCT00586378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study
Lead sponsor
ELA Medical, Inc.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
December 31, 2009
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sudden cardiac death